Bortezomib-Responsive Refractory Anti-N-Methyl-d-Aspartate Receptor Encephalitis

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Maarten J. Titulaer, Lindsey McCracken, Iñigo Gabilondo et al. · The Lancet Neurology · 2013 · 3.1K citations

Life Sciences, Neurology, Neuroscience +13

The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project

Mary Gable, Heather Sheriff, Josep Dalmau et al. · Clinical Infectious Diseases · 2012 · 733 citations · Full text

Life Sciences, Infectious Diseases, Neurology +15

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis

Franziska Scheibe, Annerose Mengel, Siegfried Köhler et al. · Neurology · 2016 · 202 citations

Medicine, Neurology, Pharmacology +15

Bortezomib Treatment for Patients With Anti-<i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor Encephalitis

Volker Behrendt, Christos Krogias, Anke Reinacher‐Schick et al. · JAMA Neurology · 2016 · 80 citations · Full text

Medicine, Neurology, Pharmacotherapy +5

Paediatric anti-N-methyl-d-aspartate receptor encephalitis: The first Italian multicenter case series

Stefano Sartori, Margherita Nosadini, Elisabetta Cesaroni et al. · European Journal of Paediatric Neurology · 2015 · 59 citations

Medicine, Neurology, Pediatrics +10